Three months after DarioHealth launched its smartphone-connected glucometer in the US, the company reports more than 100 percent increase in growth, bringing in $669,000 in revenue in the second quarter for 2016.
The increase is understandable, considering the US is the largest market for blood glucose markets. Israel-based Dario (which has rebranded itself, after previously operating under the...
Israel-based LabStyle Innovations, maker of a smartphone-connected glucometer called Dario, has launched the device in the US, Dario secured its FDA 510(k) clearance in December.
"The US is the world's largest market for glucose monitoring and the launch of national availability represents a transformative achievement not only for Dario, but more importantly for users," LabStyle Innovations CEO...
Israel-based LabStyle Innovations, maker of a smartphone-connected glucometer called Dario, has raised $2.5 million in common stock from Canadian investor Shmuel Farhi and others. This brings the company's total funding to at least $12.5 million.
Dario is a small glucose meter that syncs with a companion app. It works with Apple iPhone 5, iPads and iPods and Android devices like the Samsung...
Israel-based LabStyle Innovations, maker of a smartphone-connected glucometer called Dario, partnered with nutrition app maker FatSecret.
Dario is a small glucose meter that syncs with a companion app. It works with Apple iPhone 5, iPads and iPods and Android devices like the Samsung Galaxy S4 and Tab. The app includes a nutrition guide, logbook, insulin calculator and monitoring system. A data...
Israel-based LabStyle Innovations announced CE mark certification for its smartphone-based glucose monitor Dario, according to a press release. In the coming months, the company will plan a soft launch of Dario in Europe to collect customer feedback and refine its roll-out strategy.
In May, LabStyle raised $10 million by common stock and planned to use the money to develop, market and manufacture...
Israel-based LabStyle Innovations, which is developing a smartphone-based glucose meter, has raised $10 million by common stock that the company plans to accredited investors. The company plans to use the money to develop, market and manufacture Dario, its smartphone-enabled diabetes management system. Dario does not have a CE mark nor does it have FDA approval. LabStyle CEO Dr. Oren Fuerst aims...
